Insights

Strategic Partnerships Petra Pharma has a history of strategic collaborations and investor interest from Acceler ator Life Science Partners and Evotec, indicating openness to co-development, licensing, or sponsored research deals that could accelerate pipeline programs.

Phosphoinositide Targeting The company specializes in phosphoinositide signaling pathway inhibition and PI-related targets, suggesting emphasis on cancer and metabolic disease programs where there may be complementarity with contract research, computational chemistry, or diagnostic tools to de-risk and advance PI-targeted therapies.

Clinical Progress Petra has pursued a Phase 1b/2 program for serabelisib in PIK3CA-mutated solid tumors, presenting a near-term opportunity for sponsored trials, investigator-initiated studies, or strategic investments around late-stage readouts.

Funding Readiness With a total funding of around 76M and modest revenue, Petra may seek partnerships to de-risk programs, provide funding for expansion, or establish milestone-driven deals to support later-stage development and commercialization.

Small-Team Agility As a small biotech with 11-50 employees, Petra is likely to value flexible, out‑sourced R&D and CRO collaborations; targeted BD activities around alliance structures, co-development, or services partnerships could yield high leverage without significant internal headcount growth.

Similar companies to Petra Pharma Corporation

Petra Pharma Corporation Tech Stack

Petra Pharma Corporation uses 8 technology products and services including WordPress, Microsoft 365, Twemoji, and more. Explore Petra Pharma Corporation's tech stack below.

  • Content Management System
  • Twemoji
    Font Scripts
  • jQuery
    Javascript Libraries
  • Google Maps
    Maps
  • PHP
    Programming Languages
  • Yoast SEO
    Search Engines
  • Bootstrap
    UI Frameworks

Media & News

Petra Pharma Corporation's Email Address Formats

Petra Pharma Corporation uses at least 2 email formats:
Petra Pharma Corporation Email FormatsExamplePercentage
FLast@petrapharmacorp.comJDoe@petrapharmacorp.com
75%
Last@petrapharmacorp.comDoe@petrapharmacorp.com
25%

Frequently Asked Questions

What is Petra Pharma Corporation's phone number?

Minus sign iconPlus sign icon
You can contact Petra Pharma Corporation's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Petra Pharma Corporation's official website and social media links?

Minus sign iconPlus sign icon
Petra Pharma Corporation's official website is petrapharmacorp.com and has social profiles on LinkedIn.

How much revenue does Petra Pharma Corporation generate?

Minus sign iconPlus sign icon
As of July 2026, Petra Pharma Corporation's annual revenue is estimated to be <$1M.

What is Petra Pharma Corporation's SIC code and NAICS code?

Minus sign iconPlus sign icon
Petra Pharma Corporation's SIC code is 8733 - Noncommercial Research Organizations and NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Petra Pharma Corporation have currently?

Minus sign iconPlus sign icon
As of July 2026, Petra Pharma Corporation has approximately 20 employees across 2 continents, including North America and Europe. Key team members include Senior Scientist: Y. Z. Explore Petra Pharma Corporation's employee directory with LeadIQ.

What industry does Petra Pharma Corporation belong to?

Minus sign iconPlus sign icon
Petra Pharma Corporation operates in the Biotechnology industry.

What technology does Petra Pharma Corporation use?

Minus sign iconPlus sign icon
Petra Pharma Corporation's tech stack includes WordPress, Microsoft 365, Twemoji, jQuery, Google Maps, PHP, Yoast SEO and Bootstrap.

What is Petra Pharma Corporation's email format?

Minus sign iconPlus sign icon
Petra Pharma Corporation's email format typically follows the pattern of FLast@petrapharmacorp.com. Find more Petra Pharma Corporation email formats with LeadIQ.

How much funding has Petra Pharma Corporation raised to date?

Minus sign iconPlus sign icon
As of July 2026, Petra Pharma Corporation has raised $76M in funding. The last funding round occurred on Apr 15, 2020.

When was Petra Pharma Corporation founded?

Minus sign iconPlus sign icon
Petra Pharma Corporation was founded in 2015.
Petra Pharma Corporation logo

Petra Pharma Corporation

BiotechnologyNew York, United States11-50 Employees

Petra Pharma Corporation is a biotechnology research company focused on drug development by targeting enzymes that regulate key cellular processes, including cell division, growth, trafficking, and signaling. It seeks to develop novel small-molecule therapies for cancer and metabolic diseases to modulate these cellular mechanisms and influence human health. Based in New York, New York, the company operates with a compact team within the biopharmaceutical landscape, pursuing early-stage research and development. The objective is to translate insights about cellular pathways into therapeutics that address unresolved disease needs.

Within its industry, Petra Pharma positions itself as a focused player pursuing enzyme-targeted interventions to influence disease-related cellular pathways. A notable development in its history is a strategic collaboration with Evotec announced in 2018.

Section iconCompany Overview

Phone number
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2015
Employees
11-50

Section iconFunding & Financials

  • $76M

    Petra Pharma Corporation has raised a total of $76M of funding over 2 rounds. Their latest funding round was raised on Apr 15, 2020 as a Debt Financing.

  • <$1M

    Petra Pharma Corporation's revenue is estimated to be in the range of <$1M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.